Metavone is a WA company developing therapeutic treatments for Alzheimers and hormone related cancers using isoflavone compounds. In September 2016 the company launched an IPO to list on the ASX, however it appears that the company abandoned those plans to become an unlisted public company.
| Name | Position | Year Started |
|---|---|---|
Managing Director
|
||
Executive Chairman
|
2002 | |
Company Secretary
|
2011 | |
Executive Director
|
